This inventor holds 2 USPTO granted patents. Top assignees: Ionis Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc.. Active years: 2007-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2022
Title: Recaldo Carty: Innovator in Oligomeric Compound Synthesis
Introduction
Recaldo Carty is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of oligomeric compounds. With a total of 2 patents, Carty's work has advanced methodologies that enhance the efficiency and cost-effectiveness of oligonucleotide synthesis.
Latest Patents
Carty's latest patents include a method of conjugating oligomeric compounds and a novel approach to oligonucleotide synthesis using alternative solvents. The first patent outlines solid phase methods for synthesizing conjugated oligomeric compounds, emphasizing the addition of a phosphoramidite functionalized conjugate group to a solid support bound oligomeric compound. This method not only increases overall yield but also offers a cost benefit compared to existing techniques. The second patent presents a method for manufacturing oligonucleotides that involve a pentavalent phosphate triester, detailing the steps from deblocking a 5' blocked-nucleoside to oxidizing the resulting oligonucleotide.
Career Highlights
Throughout his career, Carty has worked with prominent companies in the biotechnology sector, including Isis Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Carty has collaborated with notable colleagues such as Max N Moore and Mark Andrade. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Recaldo Carty's innovative approaches to the synthesis of oligomeric compounds and oligonucleotides demonstrate his commitment to advancing the field of chemistry. His patents reflect a blend of creativity and practicality, paving the way for future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

